BioCryst Pharmaceuticals
BCRX
#4498
Rank
A$3.67 B
Marketcap
A$14.45
Share price
4.71%
Change (1 day)
6.06%
Change (1 year)

BioCryst Pharmaceuticals (BCRX) - Total assets

Total assets on the balance sheet as of March 2026 : A$0.67 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's total assets are A$0.67 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

BioCryst Pharmaceuticals - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31A$0.76 B-2.64%
2024-12-31A$0.78 B3.91%
2023-12-31A$0.75 B-6.12%
2022-12-31A$0.80 B-0.37%
2021-12-31A$0.81 B86.37%
2020-12-31A$0.43 B73.87%
2019-12-31A$0.25 B20.11%
2018-12-31A$0.20 B-8.71%
2017-12-31A$0.22 B83.19%
2016-12-31A$0.12 B-25.79%
2015-12-31A$0.16 B0.43%
2014-12-31A$0.16 B205.29%
2013-12-31A$54.78 M-0.88%
2012-12-31A$55.27 M-31.06%
2011-12-31A$80.17 M-25.59%
2010-12-31A$0.10 B-31.93%
2009-12-31A$0.15 B31.86%
2008-12-31A$0.12 B-26.46%
2007-12-31A$0.16 B87.9%
2006-12-31A$86.87 M-35.95%
2005-12-31A$0.13 B223.28%
2004-12-31A$41.95 M3.63%
2003-12-31A$40.48 M-44.77%
2002-12-31A$73.3 M-36.69%
2001-12-31A$0.11 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Gilead Sciences
GILD
A$81.30 B 12,001.44%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$120.28 B 17,803.20%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
A$4.59 B 583.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
A$4.23 B 530.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
A$1.50 B 124.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
A$0.73 B 9.93%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
A$12.07 M-98.20%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
A$40.67 M-93.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
A$2.11 B 214.16%๐Ÿ‡บ๐Ÿ‡ธ USA